Invasive aspergillosis is the most frequent opportunistic filamentous fungal infection causing excessive morbidity and mortality in immunocompromised patients (9, 12). Mononuclear phagocytes constitute a prominent component of the host defense against Aspergillus spp. (24). In particular, NADP (NADPH)-dependent production of antifungal compounds, such as superoxide anion (O 2 Ϫ ), hydrogen peroxide (H 2 O 2 ), and H 2 O 2 -dependent intracellular intermediates (DIIs), contributes to phagocyte-induced damage of microorganisms including fungi (2,8,16). While O 2 Ϫ production is an early event of oxidative burst, H 2 O 2 and DIIs consisting of compounds such as hydroxyl radical and HOCl are produced at late steps and are even more powerful oxidizing species.For decades, deoxycholate amphotericin B (DAMB) has been considered to be the cornerstone of antifungal therapy for fungal infections including invasive aspergillosis (1, 21). However, due to frequent infusion-related reactions and doselimiting nephrotoxicity, less-toxic lipid-associated formulations, such as liposomal amphotericin B (LAMB), amphotericin B lipid complex (ABLC), and amphotericin B colloidal dispersion (ABCD), have been developed (5,7,15). These compounds appear to offer a better therapeutic index than DAMB, circumscribing excessive toxicity (5, 7). Although newer azoles and echinocandins have been added to the antifungal armamentarium, amphotericin B formulations remain important agents against invasive aspergillosis.While lipid formulations of amphotericin B differ in their degree of induction of infusion-related reactions, little is known about their immunomodulatory effects when each of them is combined with phagocytes against Aspergillus fumigatus. Specifically, DAMB and ABLC were found to additively augment the fungicidal activity of pulmonary alveolar macrophages against conidia of A. fumigatus (17). However, the studies of the effects of DAMB on oxidative burst of phagocytes as evidenced by O 2 Ϫ production have shown contradictory results (18,22,25,26). To date, there are no reports published on the comparative effects of the four formulations on the antifungal activity of monocytes (MNCs) against A. fumigatus. We therefore investigated whether DAMB, LAMB, ABLC, and ABCD enhance the antifungal activities of monocytes against hyphae of A. fumigatus, as evidenced by monocyte-mediated hyphal damage, production of O 2 Ϫ , and production of H 2 O 2 as well as secondary DIIs, both in response to A. fumigatus.